Pharmaceuticals News and Research

RSS

American Asthma Foundation awards $750,000 to Dr.Charles Zuker

Dr. Charles Zuker, a renowned expert on the nerves that determine taste and smell, has been awarded $750,000 by the American Asthma Foundation (AAF). Dr. Zuker will apply his expertise to asthma by defining the nerves that contract the airways during an asthma attack in order to reduce the severity of these episodes.

19 Aug 2009

Gloucester Pharma announces FDA Advisory Committee Meeting to discuss Romidepsin NDA

Gloucester Pharmaceuticals will discuss the New Drug Application for romidepsin to treat patients with cutaneous T-cell lymphoma (CTCL) at the Oncologic Drugs Advisory Committee (ODAC) meeting on September 2, 2009.

18 Aug 2009

Labopharm comments on outcome of patent-infringement litigation initiated by Purdue Pharma

Labopharm Inc. today commented on the outcome of patent-infringement litigation initiated by Purdue Pharma Products L.P. against Par Pharmaceutical Companies, Inc. relating to Ultram(R) ER (tramadol hydrochloride extended-release tablets). The patents-in-suit are owned by Purdue and are licensed to Ortho-McNeil, Inc., the marketer of Ultram(R) ER.

18 Aug 2009

Par Pharmaceutical wins in Ultram ER litigation

Par Pharmaceutical Companies, Inc. today announced that the U.S. District Court for the District of Delaware has ruled in favor of Par in its challenge of Purdue's patents relating to extended-release tramadol, which are listed in the Orange Book for Ortho-McNeil's Ultram(R) ER product.

18 Aug 2009

Synco Bio to manufacture Versartis type 2 diabetes drug candidate

SynCo Bio Partners, a Netherlands based biopharmaceutical contract manufacturer, and Versartis, Inc. today announced a strategic partnership to produce Versartis' lead drug candidate VRS-859, a novel GLP-1 analog for monthly dosing to treat type 2 diabetes Under the agreement, SynCo will further develop the Versartis existing production process for VRS-859 and optimize the manufacturing process to increase yields for the forthcoming cGMP production.

18 Aug 2009

U.S. District Court rules against Lilly regarding Gemzar patent

Eli Lilly and Company today announced that the U.S. District Court for the Eastern District of Michigan has granted a motion by Sun Pharmaceuticals for partial summary judgment.

17 Aug 2009

Boehner blasts Phrma on deal with White House

The drug industry’s decision to agree to $80 billion in concessions to the White House was short-sighted, will hurt drug manufacturers and their customers, and "has all the markings of a deal gone sour," House Minority Leader John Boehner wrote Monday to his former colleague, Billy Tauzin, who now heads the Pharmaceutical Research and Manufacturers of America.

17 Aug 2009

Labopharm comments on outcome of patent-infringement litigation initiated by Purdue Pharma

17 Aug 2009

FDA approves Extavia for multiple sclerosis

The US Food and Drug Administration (FDA) has approved Extavia(R) (interferon beta-1b), the first in a new planned portfolio of multiple sclerosis (MS) medicines from Novartis to help patients manage this devastating disease.

17 Aug 2009

New consortium to tackle African sleeping sickness and Leishmaniasis

A new consortium has been formed to boost drug development for the treatment of two deadly diseases, African sleeping sickness and Leishmaniasis, which affect millions of people worldwide.

17 Aug 2009

Discovery of inherited gene variants that account for 37 percent of childhood acute lymphoblastic leukemia

Scientists at St. Jude Children’s Research Hospital have identified inherited variations in two genes that account for 37 percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may help predict drug response.

16 Aug 2009

New target for Alzheimer's disease

For close to a decade, pharmaceutical researchers have been in hot pursuit of compounds to activate a key nicotine receptor that plays a role in cognitive processes. Triggering it, they hope, might prevent or even reverse the devastation wrought by Alzheimer’s disease.

16 Aug 2009

Mylan Pharmaceuticals receives final FDA report on Morgantown, W.Va., manufacturing facility

Mylan Inc. (Nasdaq: MYL) today announced that the U.S. Food and Drug Administration (FDA) has released its official and final report regarding the agency's review of allegations made in a July newspaper article concerning the company's Morgantown, W.Va., manufacturing facility.

14 Aug 2009

MSNBC's Rachel Maddow misleading viewers on who's funding the anti-Obama health care ads

The National Republican Trust PAC announced Monday a national television ad buy hammering official Washington on irresponsible spending and the trillions planned for government-run health care. NRTP accepts no corporate money and is funded solely by the donations from average Americans, mostly in the amounts of $25 to $50. During the 2008 campaign season, the Center for Responsive Politics noted that in just one month of activity, NRTP surpassed left-wing billionaire George Soros' MoveOn.org in independent expenditures.

13 Aug 2009

Molecules wrestle for supremacy to dictate the physical state of superstructures

Research at the University of Liverpool has found how mirror-image molecules gain control over each other and dictate the physical state of superstructures.

13 Aug 2009

First batch of cancer vaccine from Cancer Vaccine Collaborative goes into trial

The first batch of NY-ESO-1 recombinant protein produced in a facility supported entirely by non-profit entities has successfully cleared regulatory review and has entered clinical testing. The clinical trials are part of the Cancer Vaccine Collaborative, a joint program of the Cancer Research Institute, Inc. (CRI) and the Ludwig Institute for Cancer Research Ltd. (LICR).

13 Aug 2009

HIV/AIDS funding, treatment standards, empowering women addressed at ICAAP

Funding to fight the spread of HIV/AIDS in Asia and the Pacific has fallen short of the demand, and the majority of available money has missed reaching those at highest risk -- Swarup Sarkar, director of Asia unit for the Global Fund to Fight AIDS, Tuberculosis and Malaria -- said during a session at the 9th International Congress on AIDS in Asia and the Pacific (ICAAP) in Bali, Indonesia, the Jakarta Post reports.

13 Aug 2009

Discovery of compounds that selectively kills cancer stem cells

The cancer stem cells that drive tumor growth and resist chemotherapies and radiation treatments that kill other cancer cells aren't invincible after all. Researchers reporting online on August 13th in the journal Cell, a Cell Press publication, have discovered the first compound that targets those cancer stem cells directly.

13 Aug 2009

Aryx Therapeutics reports Q2 2009 financials

ARYx Therapeutics, Inc. (NASDAQ:ARYX) today reported results of operations and provided a general business update for the second quarter ended June 30, 2009.

13 Aug 2009

Ad wars: Intensity picks up during August recess

The National Republican Congressional Committee is targeting a Democrat on health care reform for the first time, as ad wars — and message wars — continue between parties, Roll Call reports.

13 Aug 2009